MYAMDIA Trademark

Trademark Overview


On Monday, September 12, 2022, a trademark application was filed for MYAMDIA with the United States Patent and Trademark Office. The USPTO has given the MYAMDIA trademark a serial number of 97587797. The federal status of this trademark filing is REGISTERED as of Tuesday, April 9, 2024. This trademark is owned by Takeda Pharmaceuticals International AG. The MYAMDIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, preparations for enzyme replacement therapy for thrombotic disorders; Pharmaceutical preparations for treatment of thrombotic disorders by means of enzyme replacement therapy
myamdia

General Information


Serial Number97587797
Word MarkMYAMDIA
Filing DateMonday, September 12, 2022
Status700 - REGISTERED
Status DateTuesday, April 9, 2024
Registration Number7350576
Registration DateTuesday, April 9, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 23, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, preparations for enzyme replacement therapy for thrombotic disorders; Pharmaceutical preparations for treatment of thrombotic disorders by means of enzyme replacement therapy

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 28, 2022
Primary Code005
First Use Anywhere DateThursday, January 1, 1970
First Use In Commerce DateThursday, January 1, 1970

Trademark Owner History


Party NameTakeda Pharmaceuticals International AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGlattpark-Opfikon, CH 8152

Party NameTakeda Pharmaceuticals International AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGlattpark-Opfikon, CH 8152

Party NameTakeda Pharmaceuticals International AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGlattpark-Opfikon, CH 8152

Trademark Events


Event DateEvent Description
Saturday, June 24, 2023NON-FINAL ACTION WRITTEN
Thursday, September 15, 2022NEW APPLICATION ENTERED
Wednesday, September 28, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, June 24, 2023ASSIGNED TO EXAMINER
Saturday, June 24, 2023NON-FINAL ACTION E-MAILED
Saturday, June 24, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 19, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 15, 2023ASSIGNED TO LIE
Tuesday, December 19, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 19, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 19, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 3, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 23, 2024PUBLISHED FOR OPPOSITION
Tuesday, January 23, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 9, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, April 9, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED